Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3013224 | 1.00 | ALDH1A1 (0.41) | ALDH1A1POLBMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3013219 | 1.00 | ALDH1A1 (0.41) | ALDH1A1POLBMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3020066 | 1.00 | ALDH1A1 (0.41) | ALDH1A1POLBMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3020061 | 1.00 | ALDH1A1 (0.41) | ALDH1A1POLBMAPTSMN1; SMN2KMT2A | |
| SCHEMBL13984699 | 0.93 | TSHR (0.40) | ALDH1A1POLBMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3014137 | 0.92 | KMT2A (0.43) | ALDH1A1POLBMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3014135 | 0.92 | KMT2A (0.43) | ALDH1A1POLBMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3014132 | 0.92 | KMT2A (0.43) | ALDH1A1POLBMAPTSMN1; SMN2KMT2A | |
| SCHEMBL3019669 | 0.90 | KMT2A (0.42) | MAPTSMN1; SMN2KMT2A | |
| SCHEMBL13245274 | 0.90 | KMT2A (0.42) | MAPTSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170088549-A1 | ANTIBACTERIAL AGENTS | ACHAOGEN, INC. | 2017-03-30 | — | — | US | disclosed |
| EP-2170814-B1 | ANTIBACTERIAL AGENTS | ACHAOGEN INC (US) | 2016-08-17 | — | — | EP | disclosed |
| EP-2662353-A2 | Antibacterial agents | Achaogen, Inc. (US) | 2013-11-13 | — | — | EP | disclosed |
| US-20100190766-A1 | ANTIBACTERIAL AGENTS | ACHAOGEN, INC. (US) | 2010-07-29 | — | — | US | disclosed |
| EP-2170814-A2 | ANTIBACTERIAL AGENTS | Achaogen, Inc. (US) | 2010-04-07 | — | — | EP | disclosed |
| WO-2008154642-A2 | ANTIBACTERIAL AGENTS | ACHAOGEN, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170088549-A1 | ANTIBACTERIAL AGENTS | MRPL21, SI, ABCB11 | ALDH1A1 687/4885POLB 671/4885MAPT 4643/4885 |
| US-20100190766-A1 | ANTIBACTERIAL AGENTS | MRPL21, SI, ABCB11 | ALDH1A1 687/4885POLB 671/4885MAPT 4643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.